continuous freeze-drying and its relevance to the pharma

27
Engineering Conferences International ECI Digital Archives Integrated Continuous Biomanufacturing III Proceedings 9-19-2017 Continuous freeze-drying and its relevance to the pharma/biotech industry Roberto Pisano Politecnico di Torino, [email protected] Luigi C. Capozzi Politecnico di Torino Bernhardt Trout Massachuses Institute of Technology Follow this and additional works at: hp://dc.engconfintl.org/biomanufact_iii Part of the Engineering Commons is Abstract and Presentation is brought to you for free and open access by the Proceedings at ECI Digital Archives. It has been accepted for inclusion in Integrated Continuous Biomanufacturing III by an authorized administrator of ECI Digital Archives. For more information, please contact [email protected]. Recommended Citation Roberto Pisano, Luigi C. Capozzi, and Bernhardt Trout, "Continuous freeze-drying and its relevance to the pharma/biotech industry" in "Integrated Continuous Biomanufacturing III", Suzanne Farid, University College London, United Kingdom Chetan Goudar, Amgen, USA Paula Alves, IBET, Portugal Veena Warikoo, Axcella Health, Inc., USA Eds, ECI Symposium Series, (2017). hp://dc.engconfintl.org/biomanufact_iii/70

Upload: others

Post on 06-Feb-2022

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Continuous freeze-drying and its relevance to the pharma

Engineering Conferences InternationalECI Digital Archives

Integrated Continuous Biomanufacturing III Proceedings

9-19-2017

Continuous freeze-drying and its relevance to thepharma/biotech industryRoberto PisanoPolitecnico di Torino, [email protected]

Luigi C. CapozziPolitecnico di Torino

Bernhardt TroutMassachusetts Institute of Technology

Follow this and additional works at: http://dc.engconfintl.org/biomanufact_iii

Part of the Engineering Commons

This Abstract and Presentation is brought to you for free and open access by the Proceedings at ECI Digital Archives. It has been accepted for inclusionin Integrated Continuous Biomanufacturing III by an authorized administrator of ECI Digital Archives. For more information, please [email protected].

Recommended CitationRoberto Pisano, Luigi C. Capozzi, and Bernhardt Trout, "Continuous freeze-drying and its relevance to the pharma/biotech industry"in "Integrated Continuous Biomanufacturing III", Suzanne Farid, University College London, United Kingdom Chetan Goudar,Amgen, USA Paula Alves, IBET, Portugal Veena Warikoo, Axcella Health, Inc., USA Eds, ECI Symposium Series, (2017).http://dc.engconfintl.org/biomanufact_iii/70

Page 2: Continuous freeze-drying and its relevance to the pharma

ICB III 2017 – Integrated Continuous Manufacturing IIISeptember 17-21, 2017, Cascais, Portugal

Continuous freeze-drying and its relevance to the pharma/biotech

industry

Roberto PisanoDepartment of Applied Science and TechnologyPOLITECNICO di TORINO

Page 3: Continuous freeze-drying and its relevance to the pharma

Freeze–drying /Lyophilization isa process where water, or another solvent, is removed from afrozen solution at low temperature and pressure via sublimation

Introduction

2

A freeze–drying cycle encompasses three steps

Freezing

Primary drying

Secondary drying

Almost 50% of biopharmaceuticals listed by FDA and EMA is lyophi-lized, proving that freeze-drying is the preferred way to stabilize largemolecules that are not stable in liquid, despite its high energy con-sumptions and long processing time.

Page 4: Continuous freeze-drying and its relevance to the pharma

Introduction

3

Freeze-drying of pharmaceuticals is performed batch-wise

Long and expensive process

Heat and mass transfer is not uniform within the batch of vials

Heterogeneity in freezing behavior

Heterogeneity in drying behavior

Poor control of product quality

vial

-to-

vial

hete

roge

neity

Examples of lyophilized samples belonging to the same lot of production

Page 5: Continuous freeze-drying and its relevance to the pharma

Background & Problem statement

4

Past

Disconnected

process steps

Traditional

Batch

Manufacturing

Present

QbD & PAT

Understanding

role and impact of

individual steps

Near future

>2020

Blue-sky thinking

Continuous Manufacturing

Seamlessly integrated & full

characterized process

Page 6: Continuous freeze-drying and its relevance to the pharma

Drawbacks of batch freeze-drying

5

Heterogeneity in freezing behavior …

temperature of nucleation is not uniform within the batch of vials,but is stochastically distributed,

Distribution of the nucleation temperature as observed in a batch freeze-drying cycle

0

0.05

0.1

0.15

0.2

0.25

0.3

0.35

-6 -7 -8 -9 -10 -11 -12 -13

no

. via

ls/y

ield

Nucleation temperature, °C

Page 7: Continuous freeze-drying and its relevance to the pharma

Drawbacks of batch freeze-drying

6

Heterogeneity in freezing behavior …

temperature of nucleation is not uniform within the batch of vials,but is stochastically distributed

ice structure and, hence, cake morphology changes from vial to vial0 1 2 3 4 5 6

0

20

40

60

80

100

120

No

. o

f via

ls

Residual moisture , %

100 m100 m

(A)

Tn = -10 °C Tn = -15 °C

SEM micrographs of mannitol 5% as produced by batch freeze-drying

Page 8: Continuous freeze-drying and its relevance to the pharma

7

Drawbacks of batch freeze-drying

Heterogeneity in freezing behavior …

temperature of nucleation is not uniform within the batch of vials,but is stochastically distributed

ice structure and, hence, cake morphology changes from vial to vial

both primary and secondary drying behavior change from vial to vial

vial-to-vial variations in polymorphs composition

large distributions in residual moisture and potentially in APIactivity/stability

Continuous freeze-drying might be beneficial to …

achieve a narrow distribution in nucleation temperature

make the frozen product morphology more uniform

make drying behavior more uniform among the vials of the batch

reduce vial-to-vial heterogeneity

Page 9: Continuous freeze-drying and its relevance to the pharma

8

Drawbacks of batch freeze-drying

Heterogeneity in heat transfer …

1234567

0

5

10

15

20

25

K J I H G F E D C B A

Kv, W

m-2K

-1

1

2

3

4

5

6

7

Spatial and statistical distribution of the heat transfer coefficient, between shelf and container, within a batch of vials. Data refer to primary drying, 10 Pa as chamber pressure

Page 10: Continuous freeze-drying and its relevance to the pharma

9

Drawbacks of batch freeze-drying

Heterogeneity in heat transfer …

Evolution of pressure ratio as observed in a batch freeze-dryer

0 1 2 3 4 5 6 70

20

40

Batch freeze-drying Continuous freeze-drying

Nu

mb

er

of

via

ls,

%

Cw (% kgH2O kgdried -1

)

0 1 2 3 4 5 6 70

20

40

60

80

100

Cw (% kgH2O kgdried -1

)

Statistical distribution of the residual moisture within the lyophilized

samples at the end of primary drying

Page 11: Continuous freeze-drying and its relevance to the pharma

10

Drawbacks of batch freeze-drying

Variations in product morphology due to freezing

Variations in the residual moisture at the end of primary drying

Variations in the residual moisture at the end of secondary drying

Statistical distribution of residualmoisture within the lyophilizedsamples as observed at the end ofsecondary drying

The extent of heterogeneity infreezing and drying behavior isequipment-specific.

A cycle developed in a laboratoryfreeze-dryer cannot betransferred without modificationsto the production unit scale up

Page 12: Continuous freeze-drying and its relevance to the pharma

11

A new concept for the continuous freeze-drying of unit doses

OBJECTIVE: development of a continuous freeze-dryer that produces afinal product having similar properties and structures to that obtainedby a conventional batch unit.

FILLING CONDITION-ING

VACUUM CHAMBER

PRIMARY DRYING MODULE

SECONDARY DRYING MODULE

BACK/STOPPERING

Page 13: Continuous freeze-drying and its relevance to the pharma

12

A new concept for the continuous freeze-drying of unit doses

Filling and LoadingConditioning moduleNucleation moduleFreezing modulePrimary drying moduleSecondary drying module

Moving of vials

The continuous flow of vials is achieved by suspending the vials over a track uniformity in heat transfer

Page 14: Continuous freeze-drying and its relevance to the pharma

13

A new concept for the continuous freeze-drying of unit doses

Filling and Loading

Conditioning moduleNucleation moduleFreezing modulePrimary drying moduleSecondary drying module

Page 15: Continuous freeze-drying and its relevance to the pharma

14

A new concept for the continuous freeze-drying of unit doses

Filling and LoadingConditioning module

Nucleation moduleFreezing modulePrimary drying moduleSecondary drying module

Example of nucleation chambers

Page 16: Continuous freeze-drying and its relevance to the pharma

15

A new concept for the continuous freeze-drying of unit doses

Filling and LoadingConditioning moduleNucleation module

Freezing modulePrimary drying moduleSecondary drying module

Cold air INLET(from the cooling system)

“WARM”air OUTLET (to the cooling system)

The nucleated solution is further cooled by forced convection until the its complete solidification.

The external surface of the vessel is equally flushed by the cryogenic gas.

Different freezing protocols can be performed modulating temperature and velocity of cryogenic gas.

Page 17: Continuous freeze-drying and its relevance to the pharma

16

A new concept for the continuous freeze-drying of unit doses

Filling and LoadingConditioning moduleNucleation moduleFreezing module

Primary drying moduleSecondary drying module

Vacuum system(condenser + vacuum pump)

Cooling/heating system

Sluice-gate/load-lock

In the primary drying module …

Vials are exposed to low temperature and pressure

Heat is transferred by radiation from temperature-controlled surfaces

Page 18: Continuous freeze-drying and its relevance to the pharma

17

A new concept for the continuous freeze-drying of unit doses

Filling and LoadingConditioning moduleNucleation moduleFreezing modulePrimary drying

Secondary drying module

In the secondary drying module …

Vials are exposed to high temperature and low pressure so as to promote desorption of bounded water

Vacuum system(condenser + vacuum pump)

Cooling/heating system

Sluice-gate/load-lock

Stoppering/sealing

Page 19: Continuous freeze-drying and its relevance to the pharma

18

A new concept for the continuous freeze-drying of unit doses

Flexibility & Modularity

The various modules can be combined to make the system more flexible and treating products from different upstream feeds.

Page 20: Continuous freeze-drying and its relevance to the pharma

19

Experimental results

SEM images of lyophilized mannitol samples produced on constant drying conditions. Images refer to the same enlargement

Batch Continuous

Product morphology

More precise control of freezing conditions

Larger pores and hence smaller resistance to mass transfer during primary drying

Page 21: Continuous freeze-drying and its relevance to the pharma

20

Experimental results

Product morphology

More precise control of freezing conditions

Larger pores and hence smaller resistance to mass transfer during primary drying

Intra-vial heterogeneity is less evident

Batch

Continuoustop

center

bottom

SEM images of lyophilized mannitol samples

Page 22: Continuous freeze-drying and its relevance to the pharma

21

Experimental results

Process performances

Larger pores and hence shorter primary drying

Breaks of a typical batch production can be 20% to 50% of the total cycle time

The overall cycle time is up to 5 times shorter

Load

ing

Leak

tes

t

Free

zing

Prim

ary

dryi

ng

Soa

ktim

e

Sec

onda

ry

dryi

ng

Clo

sing

Unl

oadi

ng

Def

rost

/CIP

/SIP

/H2O

2

Batch✓

5 h✓

2-3 h✓

6 h✓

LONG✓

6 h✓

SHORT✓

1 h✓

6 h✓

6 h

Continuous✓

< 1 h✓

SHORTER✓

SHORT

Page 23: Continuous freeze-drying and its relevance to the pharma

22

Experimental results

Process performances

Larger pores and hence shorter primary drying

Breaks of a typical batch production can be 20% to 50% of the total cycle time

The overall cycle time is up to 5 times shorter

Distribution of the residual moisture at the end of drying is more uniform

Distribution of the final residual moisture for a sucrose-based formulation (250 vials)

0 1 2 3 4 5 6 70

20

40

Batch freeze-drying Continuous freeze-drying

Nu

mb

er

of

via

ls,

%

Cw (% kgH2O kgdried -1

)

0 1 2 3 4 5 6 70

20

40

60

80

100

Cw (% kgH2O kgdried -1

)

Batch Continuous

Page 24: Continuous freeze-drying and its relevance to the pharma

Equipment size

Case study #1 – 100,000 vials/week

The equipment volume is approx. 15 times smaller

23

Experimental results

0.0

2.0

4.0

6.0

8.0

10.0

12.0

14.0

16.0

18.0

Batch Continuous

Ch

amb

er v

olu

me,

m3

Precautionary cycles (100,000 vials/w)

Total volume, m^3 freezing module, m 3̂ primary drying module, m^3 secondary drying module, m^3

Page 25: Continuous freeze-drying and its relevance to the pharma

24

Conclusions

Reduce the risk of product contamination

No manual handling, increased safety The processing time is shorter

Modular and smaller equipment and facilities

More flexible operationReduced inventoryLower capital costs, less work-in-progress materials

Eliminate scale-up from lab to production units

Process flexibility

Bulk vs. particle-based materialYield can be adjusted on market request

Improve product quality

Uniformity of the lot of productionIn-line control of product quality

Page 26: Continuous freeze-drying and its relevance to the pharma

25

Acknowledgements

Massachusetts Institute of Technology

Department of Chemical Engineering

Prof. Bernhardt Trout

Politecnico di Torino

Department of Applied Science and Technology

Andrea ArsiccioFiora ArtusioMarco BazzanoLuigi C. Capozzi

Page 27: Continuous freeze-drying and its relevance to the pharma

26

Thanks foryour attention!